• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Omaha: Deceased patient had both survivor serum and Zmapp treatment

Emily

Emily

Editor, Senior Moderator
http://journals.lww.com/nursingmanagement/blog/thinkaboutit/pages/post.aspx?PostID=71
Posted by Nursing Management at 8:51 AM
Monday, November 17, 2014
A second Ebola death in the United States
Another doctor being treated for Ebola in the United States has passed away. Dr. Martin Salia died today while being treated in an Omaha hospital. Despite having the signs and symptoms of the virus, he initially tested negative on November 6th. Then, a week ago, he tested positive.

According to the healthcare professionals treating Dr. Salia, he arrived in Omaha with kidney and respiratory failure, which are advanced symptoms of Ebola. His treatment included ?kidney dialysis and ventilation as well as a blood plasma transfusion from a patient recovered from Ebola and an experimental drug, ZMapp.?
Click to expand...
 
You must log in or register to reply here.
Back
Top